We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > HMP

News List

Tevogen Bio Secures Funding from Team of Doctors to Support Clinical Trials of Its Investigational Curative T Cell Therapy for COVID-19 prnewswire
January 26, 2021
Tevogen Bio announced it has secured necessary funding from HMP Partners of New Jersey, an investment firm managed by medical doctors, which will allow Tevogen to support all clinical trials of its investigational, potentially curative COVID-19 treatment.
Li Ka-shing Announced His Retirement, but His “Pharmaceutical Empire” is just Starting Yuntian
March 30, 2018
Li Ka-shing officially announced his retirement at a press conference recently, which has aroused wide attention from China and outside China.